Go homepage(回首页)
Upload pictures (上传图片)
Write articles (发文字帖)

The author:(作者)
published in(发表于) 2016/5/9 4:26:03
Yunnan baiyao in response to sulfur was detected: detection methods are unethical

English

中文

Yunnan baiyao in response to sulfur was detected: detection method unethical | Yunnan baiyao | sulfur _ news

Original title: Yunnan baiyao in response to sulfur was detected: in line with national standards


CNS, Kunming, May 9 (reporter Wang Yanlong)-Yunnan baiyao group company limited on 9th on its official website "information note", in response to media reports "the sulfur was detected" issue, saying that the company produces children's treasure of Tai Kang granule in conformity with Chinese Pharmacopeia (2015 version) standard, the product is safe and effective.


Beijing, reporter called Yunnan baiyao group company limited, the company said, attention is paid to the economic information daily on May 6, 2016 and appeared many common cough medicine sulphur was detected involving Tai Chi, tonghua, Hayao, Yunnan baiyao group and other leading pharmaceutical companies, reported about the sulfur was detected in Bao Tai Kang granule in children. In this regard, the company attaches to reports involves comprehensive verification Bao Tai Kang granule in children's products, including drug procurement, supplier qualification, incoming inspection, drug production, and the whole process once again confirm the company's pharmaceutical production in full compliance with the requirements of good manufacturing practices GMP.


"Situation description" in the pointed out that, Yunnan baiyao by China pharmacopoeia of determination method on herbs, and pieces and the finished in the sulfur dioxide residues volume for detection, meet national standards; by Yunnan province food drug supervision authority sampling, Yunnan province food drug test by detection, company children treasure Taikang particles SO2 residues are is less than 10mg/kg, and Zhejiang Fritillaria herbs is less than 20mg/kg, far below herbs, and pieces national standards requirements is less than 150mg/kg of standard value.


Yunnan baiyao think that media coverage is based on the XI ' an Alliance of quality technology limited results, the standard basis for GB3150 12,010, applicable to the use of industrial sulphur by processing, processing and purification, food additive of sulfur. Testing method for GB/T2449 12,006, for detection of medicinal herbs, herbs have no applicability. As a professional inspection, XI ' an Alliance of quality inspection technology of sulfur detection of co in accordance with industry standards, issued drug test outcome of, some basic standards of business and contrary to basic professional ethics.


Yunnan baiyao, mentioned in the report "reporter on the drug sulphur over recent links to the above 4 pharmaceutical companies interviewed, concurrent to a written outline of the interview, but had not received a reply as of press time", the fact is that: Yunnan baiyao has not received the report in respect thereof to any outline. The media reports to the society, to regulators and enterprises causing serious adverse effects of Yunnan baiyao will retain the right to pursue its responsibilities according to law. (End)



Responsible editor: Wang Hao





Article keywords:
Yunnan baiyao sulfur

I want feedback
Save a Web page
China News Network
云南白药回应被检出硫磺:检测方法有违职业道德|云南白药|硫磺_新闻资讯

  原标题:云南白药回应被检出硫磺事件:符合国家标准


  中新网昆明5月9日电 (王艳龙)云南白药集团股份有限公司9日下午在其官方网站发布“情况说明”,回应媒体报道“被检出硫磺”一事,称公司所生产的小儿宝泰康颗粒符合《中国药典》(2015年版)标准,产品安全、有效。


  中新网记者致电云南白药集团股份有限公司,该公司表示,关注到《经济参考报》于2016年5月6日刊出的《多种常见止咳药被检出硫磺 涉及太极、通化、哈药、云南白药集团等知名药企》,报道了小儿宝泰康颗粒中检出硫磺一事。对此,该公司高度重视,对报道所涉及的小儿宝泰康颗粒产品进行了全方位核查,包括药材采购、供应商资质、进厂检测、药品生产等全过程,再次确认公司药品生产完全符合药品生产质量管理规范GMP的要求。


  “情况说明”中指出,云南白药按《中国药典》的测定方法对药材、饮片及成品中二氧化硫残留量进行检测,符合国家标准;经云南省食品药品监督管理局抽样,云南省食品药品检验所检测,公司小儿宝泰康颗粒SO2残留均小于10mg/kg、浙贝母药材小于20mg/kg,远低于药材、饮片国家标准要求小于150mg/kg的标准值。


  云南白药认为,该媒体报道依据的是西安国联质量检测技术有限公司的检测结果,其标准依据为GB3150一2010,适用于使用工业硫磺经加工、处理、提纯制得的食品添加剂硫磺。检测方法为GB/T2449一2006,对于药材、饮片的检测不具适用性。作为专业检验机构,西安国联质量检测技术有限公司按照工业硫磺检测标准、方法出具药品检定结论的做法,有失基本的业务水准和有违基本的职业道德。


  云南白药表示,报道中提及“记者就上述药品硫磺超标问题不久前分别联系上述4家药企采访,并发去了书面采访提纲,但截止记者发稿时均未收到回复”,事实是:云南白药至今未收到该报就此事发来的任何采访提纲。该媒体的报道给社会、给监管部门和企业造成了严重的不良影响,云南白药将保留依法追究其相关责任的权利。(完)



责任编辑:王浩成





文章关键词:
云南白药 硫磺

我要反馈
保存网页
中国新闻网




If you have any requirements, please contact webmaster。(如果有什么要求,请联系站长)





QQ:154298438
QQ:417480759